The Health Technology Assessment research group is responsible for the research programmes in the field of health economics, in particular the so-called health technology assessment (HTA). This involves determining the implications of introducing, distributing and applying (new) medical technologies and assessing the resulting health gain. HTA aims to form a bridge between research and policy. Important research themes include:
- Decision-analytic modeling
- Late-phase studies & real-world evidence
- Multi-criteria decision analysis (MCDA)
- Preference measurement / Discrete choice evaluation (DCE) & Time trade off (TTO) studies.
Other relevant themes: Integrated care programs, medical devices, e-Health/telemedicine, transferability, value based health care.
Focus is on a wide , including orphan diseases, oncology, chronic obstructive pulmonary disorder (COPD), diabetes, asthma, cardiovascular diseases, mental health, rheumatoid arthritis and multiple sclerosis.
The renowned Institute for Medical Technology Assessment ) is an independent company B.V. connected to ESHPM and the HTA research group.